SCHEMBL12470432

SCHEMBL12470432

Oc1ccc(-c2nc3cc(Cl)ccc3s2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.61
GAA P10253 3/20 0.61
KDM4E B2RXH2 2/20 0.61
NPC1 O15118 2/20 0.61
ALDH1A1 P00352 2/20 0.61
RAB9A P51151 2/20 0.61
LMNA P02545 1/20 0.61
GLA P06280 1/20 0.61
MGAM O43451 1/20 0.59
SI P14410 1/20 0.59
MGAM2 Q2M2H8 1/20 0.59
APP P05067 9/20 0.58
SENP7 Q9BQF6 2/20 0.56
CASP3 P42574 1/20 0.56
SENP8 Q96LD8 1/20 0.56
SENP6 Q9GZR1 1/20 0.56
TP53 P04637 1/20 0.55
THRB P10828 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
HTT P42858 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12470519 0.87 GAA (0.56) MAPTGAAKDM4ENPC1ALDH1A1
SCHEMBL4799750 0.87 APP (0.68) MAPTGAAKDM4ENPC1ALDH1A1
SCHEMBL12470524 0.84 GAA (0.60) MAPTGAAKDM4ENPC1ALDH1A1
SCHEMBL4604185 0.84 MAPT (0.76) MAPTGAAKDM4ENPC1ALDH1A1
SCHEMBL28599530 0.83 KDM4E (0.57) MAPTGAAKDM4ENPC1ALDH1A1
SCHEMBL13254486 0.83 MAPT (0.70) MAPTGAAKDM4ENPC1ALDH1A1
SCHEMBL12471100 0.83 MGAM (0.70) MAPTGAAKDM4ENPC1RAB9A
SCHEMBL8704440 0.82 KDM4E (0.60) MAPTGAAKDM4ENPC1ALDH1A1
SCHEMBL31145129 0.82 KDM4E (0.60) MAPTGAAKDM4ENPC1ALDH1A1
SCHEMBL26686839 0.81 LOXL2 (0.60) MAPTGAAKDM4ENPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9155690-B2 Compound having skin-whitening, anti-oxidizing and PPAR activities and medical use thereof PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (KR) 2015-10-13 US claimed
WO-2012108689-A2 NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREFOR 부산대학교 산학협력단 (KR) 2012-08-16 WO claimed
US-20150366776-A1 NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREOF PUSAN NAT UNIV IND COOP FOUND (KR) 2015-12-24 US disclosed
US-9155690-B2 Compound having skin-whitening, anti-oxidizing and PPAR activities and medical use thereof PUSAN NATIONAL UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (KR) 2015-10-13 US disclosed
US-8889881-B2 Compound having skin-whitening, anti-oxidizing and PPAR activities and medical use therefor Pusan National University Industry —University Cooperation Foundation (KR) 2014-11-18 US disclosed
US-20140037564-A1 NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREFOR Pusan National University Indusrtyuniversity (KR) 2014-02-06 US disclosed
WO-2012108689-A2 NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREFOR 부산대학교 산학협력단 (KR) 2012-08-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150366776-A1 NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREOF PPARG, PPARA, TYR MAPT 1956/4885GAA 149/4885KDM4E 3430/4885
US-20140037564-A1 NOVEL COMPOUND HAVING SKIN-WHITENING, ANTI-OXIDIZING AND PPAR ACTIVITIES AND MEDICAL USE THEREFOR PPARG, PPARA, PPARD MAPT 2700/4885GAA 307/4885KDM4E 3588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.